These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37087341)

  • 1. Retraction notice to "LNCRNA CDKN2B-AS1 regulates mesangial cell proliferation and extracellular matrix accumulation via miR-424-5p/HMGA2 axis" [Biomed. Pharmacother. 121 (2020) 109622].
    Li Y; Zheng LL; Huang DG; Cao H; Gao YH; Fan ZC
    Biomed Pharmacother; 2023 Aug; 164():114728. PubMed ID: 37087341
    [No Abstract]   [Full Text] [Related]  

  • 2. LNCRNA CDKN2B-AS1 regulates mesangial cell proliferation and extracellular matrix accumulation via miR-424-5p/HMGA2 axis.
    Li Y; Zheng LL; Huang DG; Cao H; Gao YH; Fan ZC
    Biomed Pharmacother; 2020 Jan; 121():109622. PubMed ID: 31707340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA CDKN2B-AS1 regulates high glucose-induced human mesangial cell injury via regulating the miR-15b-5p/WNT2B axis.
    Chang J; Yu Y; Fang Z; He H; Wang D; Teng J; Yang L
    Diabetol Metab Syndr; 2020 Dec; 12(1):109. PubMed ID: 33298110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA CDKN2B-AS1 relieved inflammation of ulcerative colitis via sponging miR-16 and miR-195.
    Tian Y; Cui L; Lin C; Wang Y; Liu Z; Miao X
    Int Immunopharmacol; 2020 Nov; 88():106970. PubMed ID: 33182065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA CDKN2B-AS1 contributes to glioma development by regulating the miR-199a-5p/DDR1 axis.
    Lu J; Chen Y; Wen L; Zhou Q; Yan S
    J Gene Med; 2022 Jan; 24(1):e3389. PubMed ID: 34559933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cell-like cells-derived exosomal lncRNA
    Wu Q; He Y; Liu X; Luo F; Jiang Y; Xiang M; Zhao R
    Regen Ther; 2023 Mar; 22():19-29. PubMed ID: 36582605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA CDKN2B-AS1 hinders the proliferation and facilitates apoptosis of ox-LDL-induced vascular smooth muscle cells via the ceRNA network of CDKN2B-AS1/miR-126-5p/PTPN7.
    Li J; Chen J; Zhang F; Li J; An S; Cheng M; Li J
    Int J Cardiol; 2021 Oct; 340():79-87. PubMed ID: 34384839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retraction notice to "LncRNA DICER1-AS1 promotes the proliferation, invasion and autophagy of osteosarcoma cells via miR-30b/ATG5" [Biomed. Pharmacother., 104 (2018) 110-118].
    Gu Z; Hou Z; Zheng L; Wang X; Wu L; Zhang C
    Biomed Pharmacother; 2024 Mar; 172():116198. PubMed ID: 38296734
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction notice to "Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ROCK2 axis" [Biomed. Pharmacother. 125 (2020) 109882].
    Liu X; Li Y; Wen J; Qi T; Wang Y
    Biomed Pharmacother; 2022 Sep; 153():113356. PubMed ID: 35835667
    [No Abstract]   [Full Text] [Related]  

  • 10. CDKN2B-AS1 promotes the proliferation, clone formation, and invasion of nasopharyngeal carcinoma cells by regulating miR-98-5p/E2F2 axis.
    Li Z; Cai X; Zou W; Zhang J
    Am J Transl Res; 2021; 13(12):13406-13422. PubMed ID: 35035684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NNT-AS1 regulates proliferation, ECM accumulation and inflammation of human mesangial cells induced by high glucose through miR-214-5p/smad4.
    Geng Z; Wang X; Hao S; Dong B; Huang Y; Wang Y; Xu L
    BMC Nephrol; 2021 Nov; 22(1):368. PubMed ID: 34742256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CDKN2B-AS1 Promotes Cell Viability, Migration, and Invasion of Hepatocellular Carcinoma via Sponging miR-424-5p.
    Shen X; Li Y; He F; Kong J
    Cancer Manag Res; 2020; 12():6807-6819. PubMed ID: 32801906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulating of cell cycle progression by the lncRNA CDKN2B-AS1/miR-324-5p/ROCK1 axis in laryngeal squamous cell cancer.
    Liu F; Xiao Y; Ma L; Wang J
    Int J Biol Markers; 2020 Mar; 35(1):47-56. PubMed ID: 31960744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDKN2B antisense RNA 1 expression alleviates idiopathic pulmonary fibrosis by functioning as a competing endogenouse RNA through the miR-199a-5p/Sestrin-2 axis.
    Yang M; Yin E; Xu Y; Liu Y; Li T; Dong Z; Tai W
    Bioengineered; 2022 Mar; 13(3):7746-7759. PubMed ID: 35291918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retraction notice to: "LncRNA DANCR silence inhibits SOX5-medicated progression and autophagy in osteosarcoma via regulating miR-216a-5p" [Biomed. Pharmacother. 122 (2019) 109707].
    Pan Z; Wu C; Li Y; Li H; An Y; Wang G; Dai J; Wang Q
    Biomed Pharmacother; 2023 Oct; 166():114876. PubMed ID: 37353384
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of lncRNA CDKN2B-AS1 in Interventional Therapy of Liver Cancer and the Mechanism under Its Participation in Tumour Cell Growth via miR-199a-5p.
    Xu L; Wu H; Pan J; Chen Z; Du L
    J Oncol; 2022; 2022():2313416. PubMed ID: 36081669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated lncRNA Cyclin-dependent kinase inhibitor 2B antisense RNA 1 induces the proliferation and migration of colorectal cancer by miR-378b/CAPRIN2 axis.
    Zheng Y; Zeng J; Xia H; Wang X; Chen H; Huang L; Zeng C
    Bioengineered; 2021 Dec; 12(1):5476-5490. PubMed ID: 34511033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ-ACTR2 aggravates the high glucose-induced cell dysfunction of human renal mesangial cells through mediating the miR-205-5p/HMGA2 axis in diabetic nephropathy.
    Yun J; Ren J; Liu Y; Dai L; Song L; Ma X; Luo S; Song Y
    Diabetol Metab Syndr; 2021 Jun; 13(1):72. PubMed ID: 34174955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retraction notice to "LncRNA SNHG16 promotes tumor growth of pancreatic cancer by targeting miR-218-5p" [Biomed. Pharmacother. 114 (2019) 108862].
    Liu S; Zhang W; Liu K; Liu Y
    Biomed Pharmacother; 2024 Feb; 171():116188. PubMed ID: 38296726
    [No Abstract]   [Full Text] [Related]  

  • 20. LncRNA LOXL1-AS1 controls osteogenic and adipocytic differentiation of bone marrow mesenchymal stem cells in postmenopausal osteoporosis through regulating the miR-196a-5p/Hmga2 axis.
    Zhang L; Xie H; Li S
    J Bone Miner Metab; 2020 Nov; 38(6):794-805. PubMed ID: 32651705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.